[Blood doping: 2].
Blood Doping has recently obtained a large diffusion between professional and nonprofessional athletes, in particular for endurance sports it has almost become a necessary way to warrant best performance. Seven years after the publication of our article "Blood Doping", this second installment was born to emphasize the way the biomedical research supplies (often unintentionally) new drugs and new technology to improve athletic performance and, on the other hand, to underline the antidoping strategies.
Cristani
Alessandro
A
Unità Operativa di Medicina II, Dipartimento di Medicina Interna e Specialità Mediche, Ospedale Policlinico, Università degli Studi di Modena e Reggio Emilia. cristani.a@policlinico.mo.it
Boldrini
Elena
E
Amateis
Elisa
E
Arioli
Dimitriy
D
D045930:Anabolic Agents / Q000008:administration & dosage; D000068256:Darbepoetin alfa; D004300:Doping in Sports; D004921:Erythropoietin / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D004992:Ethics, Medical; D006801:Humans; D010807:Physical Endurance / Q000187:drug effects*; D010819:Physician's Role; D011994:Recombinant Proteins; D013178:Sports Medicine / Q000592:standards; D015813:Substance Abuse Detection
D045930:Anabolic Agents; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068256:Darbepoetin alfa